Biomarkers in Neurodegenerative Diseases
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease; Amnesia; Amyotrophic lateral sclerosis; Cognition disorders; Dementia; Epilepsy; Lewy body disease; Mild cognitive impairment; Motor neuron disease; Neurodegenerative disorders; Parkinson's disease; Spinocerebellar ataxias; Temporal-lobe-epilepsy
- Focus Biomarker; Diagnostic use
Most Recent Events
- 06 Nov 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 28 Oct 2019 Status changed from not yet recruiting to recruiting.
- 14 Aug 2019 New trial record